Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Plast Reconstr Surg. 2016 Mar;137(3):545e–553e. doi: 10.1097/01.prs.0000475823.01907.53

Figure 1. Systemic Treatment with Ro 32-3555 Decreases Mmp-9 Activity at the Tendon Repair Site.

Figure 1

[A]: Repaired tendons were harvested 7 days post repair. A colorimetric assay was used to measure Mmp9 activity in vehicle and Ro 32-3555 treated groups. There is a 48% decrease in Mmp9 activity in the Ro 32-3555 treated group compared to vehicle. (*) indicates p<0.0001. [B]: Zymography was used to visualize Mmp9 activity in repaired tendons harvested at 7 days post-surgery. There is a decrease in band intensity in the Ro 32-3555 treated group compared to vehicle, indicating a decrease in Mmp9 activity.